Viewing data from:

GALLIUM GA 68 EDOTREOTIDE

NDA

GALLIUM GA-68 EDOTREOTIDE | N210828 | UNIV IOWA HOSPS AND CLINICS PET IMAGING CENTER

1 strength0 unique patents2 unique exclusivities

Patent Timeline

0 unique patents, 2 exclusivities by expiration date

TodayExclusivity

Today

ODE-383

Aug. 21, 2026

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Approval Letters

3 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.5-4mCi/ML

RLDAP

0 patents2 exclusivities▴

SOLUTION;INTRAVENOUS | Approved: Aug 21, 2019

Code	Date	Status
ODE-383	Aug 21, 2026	< 1 year
W	Aug 21, 2026	< 1 year